ASXL1 and cancer: Most cancer-associated ASXL1 mutations give rise to truncated proteins that retain the amino-terminal BAP1 (BRCA1 associated protein 1)-interacting region of ASXL1, but lose the carboxy-terminal PHD domain [21, 22, 61].